3.36
price up icon8.74%   0.27
after-market Handel nachbörslich: 3.39 0.03 +0.89%
loading

Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
8.73%
-10.61
-9.7584 -5.5291 -4.3104 -18.70
Income/Loss From Continuing Operations Before Tax
9.81%
-9.6932
-8.8275 -4.5773 -28.96 1.2437
Income/Loss From Continuing Operations After Tax
9.81%
-9.6932
-8.8275 -4.5773 -3.3429 -17.46
Net Income/Loss
9.81%
-9.6932
-8.8275 -4.5773 -3.3429 -17.46
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
95.19
95.19 95.19 7.838 80.48
Diluted Average Shares
0.00%
95.19
95.19 95.19 7.838 80.48
Basic Earnings Per Share
11.11%
-0.10
-0.09 -0.05 - -0.22
Diluted Earnings Per Share
11.11%
-0.10
-0.09 -0.05 - -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):